Sanofi sees softness in U.S. vaccine demand in near term

Core Insights - The CEO of Sanofi, Paul Hudson, indicated that the U.S. is expected to experience a slight decline in vaccine demand this year due to misinformation and increased scrutiny from the current administration [1] Company Summary - Sanofi's leadership is addressing challenges in vaccine demand, highlighting external factors such as misinformation and political scrutiny that may impact public perception and uptake [1]